PureTech Health plc (PRTC)
$17.38+4.51%Close
SELLRECOVERY · day 64
Key stats
- Market cap
- $423M
- Beta
- 0.76
- P/E (TTM)
- -0.60
- 1W
- -1.47%
- 1M
- +2.90%
- vs SPY 1W
- -1.34%
- vs SPY 1M
- +0.40%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 10
- GROWTH
- 4
- GARP
- 4
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-19.1%
REV YoY-
ROE-31.8%
EPS YoY-
ROA-20.5%
GROSS-471
OP-2115
NET-2356
[VALUATION]
P/E TTM-0.60
P/E FWD-
SECTOR PE20.34
INDUSTRY PE13.84
P/B0.13
P/FCF-
EV/EBITDA-42.08
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E6.28
ALTMAN Z-
CURR RATIO6.59
ND/EBITDA-
BETA0.76
Company news
FAQ
- What is LOPJLB’s current signal on PRTC?
- LOPJLB’s latest quantitative signal on PureTech Health plc (PRTC) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is PRTC in?
- PureTech Health plc (PRTC) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does PureTech Health plc (PRTC) do?
- PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. It operates through the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Par…